AAAAAA

   
Results: 1-9 |
Results: 9
IMPROVED ORAL BIOAVAILABILITY OF THE HYPOCHOLESTEROLEMIC DMP-565 IN DOGS FOLLOWING ORAL DOSING IN OIL AND GLYCOL SOLUTIONS
Authors: BURCHAM DL MAURIN MB HAUSNER EA HUANG SM
Citation: Dl. Burcham et al., IMPROVED ORAL BIOAVAILABILITY OF THE HYPOCHOLESTEROLEMIC DMP-565 IN DOGS FOLLOWING ORAL DOSING IN OIL AND GLYCOL SOLUTIONS, Biopharmaceutics & drug disposition, 18(8), 1997, pp. 737-742
ENHANCEMENT OF THE INTESTINAL-ABSORPTION OF PEPTIDES AND NONPEPTIDES
Authors: AUNGST BJ SAITOH H BURCHAM DL HUANG SM MOUSA SA HUSSAIN MA
Citation: Bj. Aungst et al., ENHANCEMENT OF THE INTESTINAL-ABSORPTION OF PEPTIDES AND NONPEPTIDES, Journal of controlled release, 41(1-2), 1996, pp. 19-31
PHARMACOKINETICS AND METABOLISM OF EXP921, A NOVEL COGNITIVE ENHANCER, IN RATS
Authors: WONG YN QUON CY HOLM KA BURCHAM DL FREY NL HUANG SM LAM GN
Citation: Yn. Wong et al., PHARMACOKINETICS AND METABOLISM OF EXP921, A NOVEL COGNITIVE ENHANCER, IN RATS, Drug metabolism and disposition, 24(2), 1996, pp. 172-179
THE EFFECT OF ABSORPTION ENHANCERS ON THE ORAL ABSORPTION OF THE GP IIB IIIA RECEPTOR ANTAGONIST, DMP-728, IN RATS AND DOGS/
Authors: BURCHAM DL AUNGST BA HUSSAIN M GORKO MA QUON CY HUANG SM
Citation: Dl. Burcham et al., THE EFFECT OF ABSORPTION ENHANCERS ON THE ORAL ABSORPTION OF THE GP IIB IIIA RECEPTOR ANTAGONIST, DMP-728, IN RATS AND DOGS/, Pharmaceutical research, 12(12), 1995, pp. 2065-2070
A PHARMACOKINETIC EVALUATION OF HIV PROTEASE INHIBITORS, CYCLIC UREAS, IN RATS AND DOGS (VOL 15, PG 535, 1994)
Authors: WONG YN BURCHAM DL SAXTON PL ERICKSONVIITANEN S GRUBB MF QUON CY HUANG SM
Citation: Yn. Wong et al., A PHARMACOKINETIC EVALUATION OF HIV PROTEASE INHIBITORS, CYCLIC UREAS, IN RATS AND DOGS (VOL 15, PG 535, 1994), Biopharmaceutics & drug disposition, 16(2), 1995, pp. 2-2
A PHARMACOKINETIC EVALUATION OF HIV PROTEASE INHIBITORS, CYCLIC UREAS, IN RATS AND DOGS
Authors: WONG YN BURCHAM DL SAXTON PL ERICKSONVIITANEN S GRUBB MF QUON CY HUANG SM
Citation: Yn. Wong et al., A PHARMACOKINETIC EVALUATION OF HIV PROTEASE INHIBITORS, CYCLIC UREAS, IN RATS AND DOGS, Biopharmaceutics & drug disposition, 15(7), 1994, pp. 535-544
THE PHARMACOKINETICS AND METABOLISM OF DUP 532, A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN RATS AND DOGS
Authors: WONG YN HOLM KA BURCHAM DL HUANG SM QUON CY
Citation: Yn. Wong et al., THE PHARMACOKINETICS AND METABOLISM OF DUP 532, A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN RATS AND DOGS, Biopharmaceutics & drug disposition, 15(1), 1994, pp. 53-63
PHARMACOKINETICS OF HIV PROTEASE INHIBITOR DMP-323 IN RATS AND DOGS
Authors: GRUBB MF WONG YN BURCHAM DL SAXTON PL QUON CY HUANG SM
Citation: Mf. Grubb et al., PHARMACOKINETICS OF HIV PROTEASE INHIBITOR DMP-323 IN RATS AND DOGS, Drug metabolism and disposition, 22(5), 1994, pp. 709-712
METABOLISM AND DISPOSITION OF EXP631 - A NOVEL ANTIDEPRESSANT ANALGESIC
Authors: WONG YN BURCHAM DL HUANG SM QUON CY
Citation: Yn. Wong et al., METABOLISM AND DISPOSITION OF EXP631 - A NOVEL ANTIDEPRESSANT ANALGESIC, Biopharmaceutics & drug disposition, 14(6), 1993, pp. 519-531
Risultati: 1-9 |